Alicia de La Cruz Fernandez

Publications

2025

Alicia de La Cruz Fernandez, C. Ronchi, C. Bartolucci, P. G. Socuéllamos, A. D. Benito-Bueno, S. Severi, A. Zaza, C. Valenzuela (2025) RvD1 and LXA4 inhibitory effects on cardiac voltage-gated potassium channels Biomedicine and Pharmacotherapy, Vol. 187, Article 118083 (Article in journal) https://dx.doi.org/10.1016/j.biopha.2025.118083

Alicia de La Cruz Fernandez, Peter H. Larsson (2025) KCNQ1 and PIP2: it takes two to tango Cell Research, Vol. 35, p. 922-923 (Article in journal) https://dx.doi.org/10.1038/s41422-025-01189-2

Julien Louradour, Tibor Hornyik, Alicia de La Cruz Fernandez, Irene Hiniesto Iñigo, Nicolo Alerni, Miriam Barbieri, Ruben Lopez, Stefanie Perez-Feliz, Lluis Matas, Saranda Nimani, Lucilla Giammarino, Gideon Koren, Manfred Zehender, Michael Brunner, Sara I Liin, H Peter Larsson, Katja E. Odening (2025) Beneficial action potential duration-shortening effects, but deleterious negative inotropism of IKs-activator docosahexaenoyl glycine in long QT syndrome type 2 Europace, Vol. 27, Article euaf168 (Article in journal) https://dx.doi.org/10.1093/europace/euaf168

Irene Hiniesto Iñigo, Akshay Sridhar, Julien Louradour, Alicia de La Cruz Fernandez, Siri Amalia Lundholm, Amaia Jauregi Miguel, Federica Giannetti, Luca Sala, Katja E. Odening, Peter Larsson, Nina Ottosson, Sara Liin (2025) Rescue of loss-of-function long QT syndrome-associated mutations in K_V7.1/KCNE1 by the endocannabinoid N-arachidonoyl-L-serine (ARA-S) British Journal of Pharmacology, Vol. 182, p. 2861-2877 (Article in journal) https://dx.doi.org/10.1111/bph.70008

Xavier O. Scott, Nadine A. Kerr, Juliana Sanchez-Molano, Juan Pablo de Rivero Vaccari, Roey Hadad, Alicia de La Cruz Fernandez, Peter Larsson, W. Dalton Dietrich, Robert W. Keane (2025) Catecholamine-Induced Inflammasome Activation in the Heart Following Photothrombotic Stroke Translational Stroke Research, Vol. 16, p. 1317-1330 (Article in journal) https://dx.doi.org/10.1007/s12975-024-01311-3